Cellex COVID-19 Antigen Test kits recalled for lacking FDA emergency use authorization
Cellex is recalling approximately 44,821 units of its qSARS-CoV-2 Antigen Rapid Test due to lack of FDA emergency use authorization. The test was distributed nationwide in California, Florida, Texas, and Wisconsin.
- Product
- Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue"
- Category
- Medical Device
- Distribution
- Distributed nationwide